https://www.selleckchem.com/pr....oducts/Omecamtiv-mec
The HAS-BLED score was≤3 in 629 subjects and 3 in 456 subjects, respectively. Non-peri-procedural major bleeding was reduced by 11% and 9% compared with predicted rates in the low and high bleeding risk groups, respectively. LAAO with the Amplatzer Amulet reduced the risk of ischemic stroke compared with the predicted rate, with a greater magnitude among patients at high thromboembolic risk without increasing the bleeding risk. (Amplatzer™Amulet™ Post-Market Study [Amulet™PMS]; NCT02447081). LAAO with the Ampla
Me gusta
Comentario
Compartir
